Breaking Down LTIMindtree Limited Financial Health: Key Insights for Investors

LTIMindtree's latest results pack a mix of reassurance and caution for investors: Q4 FY25 revenue reached ₹97,717 million (up 9.9% YoY, 1.1% QoQ) while full-year FY25 revenue hit ₹380,081 million (up 7.0% YoY), with North America ~75% of revenue and BFSI contribution rising to 37.1%; profitability shows a Q4 EBIT margin of 13.8% (1.2% sequential gain) even as FY25 EBIT margin slipped to 14.5% and ROE eased to 21.5% from 25.0% a year earlier, cash and investments climbed to ₹13,432.8 crore and operating cash flow conversion stood at 98.8%, the balance sheet strengthened by a net worth of ₹21,295 crore and total assets exceeding ₹30,000 crore, debt facilities were trimmed to ₹1,655.25 crore with Crisil reaffirming Crisil AAA/Stable and Crisil A1+ ratings, deal wins totaled $1.6 billion in Q4 and growth levers such as the BlueVerse AI platform and a ₹7.9 billion PAN 2.0 contract point to upside even as headwinds persist in healthcare (-16.2% YoY), consumer (-1.9% YoY), European revenue (-1.5% QoQ) and margin pressure that compressed FY25 net profit margin to 12.1%-read on for a detailed, line-item breakdown investors need to weigh.

LTIMindtree Limited (LTIM.NS) Revenue Analysis

• Q4 FY25 revenue: ₹97,717 million - +9.9% YoY, +1.1% QoQ.
• FY25 revenue: ₹380,081 million - +7.0% YoY.
• BFSI share in Q4 FY25: 37.1% (vs 35.1% in Q4 FY24).
• Consumer business in Q4 FY25: -1.9% YoY.
• North America: ~75% of revenue, +6.8% YoY in Q4 FY25.
• Deal wins in Q4 FY25: $1.6 billion (prev. quarter $1.68bn; prior year $1.43bn).

• Revenue drivers: BFSI's expanding spend (37.1% of Q4), large share from North America (~75%), and sustained deal-flow ($1.6bn in Q4) underpin topline momentum.
• Areas of caution: Consumer vertical decline (-1.9% YoY) warrants monitoring for cyclical demand recovery and client-specific exposure.

LTIMindtree Limited (LTIM.NS) - Profitability Metrics

Q4 FY25 showed sequential and year-over-year improvement in quarterly profitability, while full-year FY25 reflected margin compression versus FY24 alongside lower returns on equity and capital employed.

• Q4 FY25 EBIT margin: 13.8% (up 1.2 percentage points sequentially; +2.8 ppt YoY)
• Q4 FY25 net profit margin: 11.5% (up 3.9 ppt sequentially; +2.5 ppt YoY)
• FY25 EBIT margin: 14.5% (down from 15.7% in FY24)
• FY25 net profit margin: 12.1% (down from 12.9% in FY24)
• FY25 ROE: 21.5% (vs 25.0% in FY24)
• FY25 ROCE: 27.2% (vs 30.7% in FY24)

Key drivers behind the quarterly rebound included operational gearing and one-off items that improved reported margins in Q4; however, FY25 margins and returns reflect pressure from higher operating costs and investments. For related investor context, see Exploring LTIMindtree Limited Investor Profile: Who's Buying and Why?

LTIMindtree Limited (LTIM.NS) - Debt vs. Equity Structure

• Net worth: ₹21,295 crore as of December 31, 2024 - a sizeable equity cushion supporting growth and capital allocation.
• Total bank loan facilities: Rated at ₹1,655.25 crore (reduced from ₹1,738.5 crore) - indicates active debt reduction and prudent liability management.
• Cash & investments: ₹13,432.8 crore as of March 31, 2025 (up from ₹11,559.6 crore year-on-year) - strong liquid reserves to cover near-term obligations and fund strategic spends.
• Operating cash flow conversion: 98.8% for FY25 - nearly full conversion of profits to cash, reducing refinancing needs.
• Total assets: Crossed ₹30,000 crore in FY25 - a broadening asset base consistent with scale and operating cash generation.

• Low leverage: With modest bank facilities (~₹1,655.25 crore) relative to a ₹21,295 crore net worth and >₹13,400 crore in liquid assets, the balance sheet is resilient to cyclical pressures.
• High liquidity coverage: Cash and investments can comfortably meet short-term debt and operational needs; near-100% cash conversion further supports internal funding of capex and M&A.
• Credit quality: Crisil AAA/A1+ ratings reduce refinancing risk and lower cost of capital for future borrowings.
• Scalability: A >₹30,000 crore asset base plus strong equity implies capacity to pursue inorganic opportunities without excessive leverage.

LTIMindtree Limited (LTIM.NS) - Liquidity and Solvency

Key liquidity and solvency metrics for LTIMindtree Limited (LTIM.NS) point to strengthened short‑term coverage, robust cash buffers and high-quality cash generation through FY25.

• Current ratio improved to 3.5 as of March 31, 2025, versus 3.3 as of March 31, 2024, reflecting better coverage of current liabilities by current assets.
• Days Sales Outstanding (DSO) on trade receivables and unbilled revenue improved to 79 days as of March 31, 2025, down from 80 days a year earlier, indicating slight improvement in collections and billing efficiency.
• Cash and investment balances (including strategic investments) rose to ₹13,432.8 crore as of March 31, 2025, up from ₹11,559.6 crore on March 31, 2024.
• Operating cash flow conversion remained healthy at 98.8% for FY25, signaling strong conversion of profits into cash.
• Total asset base crossed the ₹30,000 crore mark during FY25, underlining scale and balance‑sheet strength.
• Net worth stood at ₹21,295 crore as of December 31, 2024, evidencing a solid equity base.

For broader context on LTIMindtree's strategic anchors and culture that support these financial metrics, see Mission Statement, Vision, & Core Values (2026) of LTIMindtree Limited.

LTIMindtree Limited (LTIM.NS) - Valuation Analysis

• Market signal: stock closed at ₹4,536.70 on April 23, 2025, reflecting positive investor sentiment post-earnings.
• Earnings per share: EPS rose slightly from ₹154.48 in FY24 to ₹155.00 in FY25 (0.3% increase).
• Dividend stance: interim dividend increased by 10% in Q2 FY26, indicating management confidence in cash flows and earnings stability.
• Profitability trend: Q4 FY25 net profit margin at 11.5%, up 3.9 percentage points sequentially and up 2.5 percentage points year-over-year.
• Returns compression: ROE fell to 21.5% in FY25 from 25.0% in FY24; ROCE declined to 27.2% in FY25 from 30.7% in FY24.

• Absolute valuation: implied P/E ~29.3x suggests market is pricing in sustained growth and margin resilience; compare with sector peers for context.
• Profit-quality signals: rising quarterly net margins support current multiple despite near-flat EPS year-on-year.
• Capital efficiency: declines in ROE and ROCE warrant monitoring-may reflect higher equity base, lower leverage benefit, or margin pressure in earlier quarters.
• Cash return policy: 10% interim dividend uplift signals confidence in cash generation and supports yield-sensitive valuation components.
• Event sensitivity: recent positive market reaction to earnings indicates investor willingness to re-rate the stock on forward guidance and margin trajectory; follow subsequent guidance and order-book updates.

LTIMindtree Limited (LTIM.NS) - Risk Factors

LTIMindtree faces several near-term and medium-term risks that materially affect revenue growth, margins and profitability. The following points synthesize the key financial and operational red flags investors should monitor closely.

• Segmental declines: Healthcare revenue fell sharply, down 16.2% year-over-year in Q4 FY25, and the consumer business declined 1.9% YoY in Q4 FY25 - both pressuring overall top-line momentum.
• Regional headwinds: Europe revenue contracted 1.5% in Q4 FY25, highlighting exposure to slower demand in that geography.
• Margin pressures: EBIT margin compressed to 14.5% in FY25 from 15.7% in FY24, indicating weakening operating leverage.
• Profitability contraction: Net profit margin declined to 12.1% in FY25 from 12.9% in FY24, reducing free cash flow conversion and shareholder returns potential.
• Quarterly profit miss: Net profit fell 7.1% YoY in Q3 FY25, attributed to higher employee-related expenses, signaling cost-base volatility.
• Cost and staffing risks: Elevated employee-related expenses (including wage inflation, hiring, and attrition-related costs) are eroding margins and could persist if utilization and pricing do not improve.

Key risk implications for investors:

• Revenue concentration risk if underperforming segments (healthcare, consumer) and regions (Europe) fail to recover - potential for further downward revisions to guidance.
• Margin sensitivity to employee costs - continued wage inflation or lower utilization could push EBIT and net margins lower than FY25 levels.
• Earnings volatility - quarterly misses (e.g., Q3 FY25 net profit down 7.1% YoY) suggest downside risk to consensus estimates and stock valuation multiples.
• Operational execution risk - turnaround in underperforming verticals requires client wins, pricing power and cost control, all of which face execution risk.

For corporate direction and strategic context see: Mission Statement, Vision, & Core Values (2026) of LTIMindtree Limited.

LTIMindtree Limited (LTIM.NS) - Growth Opportunities

• Deal momentum: secured deal wins of $1.6 billion in Q4 FY25, reinforcing a strong sales funnel and near-term revenue visibility.
• AI platform expansion: launched BlueVerse in June 2025 to accelerate AI-driven services, platform-led engagements and cross-selling into large accounts.
• Strategic government mandate: awarded a ₹7.9 billion contract for PAN 2.0 to upgrade India's Permanent Account Number system, enhancing recurring-revenue and referenceability in the public sector.
• Shareholder signal: declared a 10% interim dividend increase in Q2 FY26, indicating management confidence in cash flow and earnings stability.

• Implication for services mix: BlueVerse can drive higher-margin, productized offerings (platform subscriptions, IP licensing) complementing traditional services, lifting overall gross and net margins over time.
• Revenue diversification: large public-sector programs like PAN 2.0 diversify LTIMindtree's client base and create multi-year implementation plus support revenues.
• Cash-flow & returns: interim dividend increase reflects healthy cash generation and a balance-sheet that can support both reinvestment in growth (R&D, acquisitions) and shareholder distributions.
• Profitability trend: 11.5% net margin in Q4 FY25, improving QoQ and YoY, signals operational leverage from higher-value deals and efficiency initiatives.